Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
75%(3 trials)

Phase Distribution

Ph phase_2
2
40%
Ph phase_3
1
20%
Ph phase_1
2
40%

Phase Distribution

2

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
2(40.0%)
Phase 2Efficacy & side effects
2(40.0%)
Phase 3Large-scale testing
1(20.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(4)
Other(1)

Detailed Status

Completed4
unknown1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (40.0%)
Phase 22 (40.0%)
Phase 31 (20.0%)

Trials by Status

completed480%
unknown120%

Recent Activity

0 active trials
Showing 5 of 5
completedphase_1

Trial for Studying Pharmacokinetic Effects of Ketoconazole on CG100649

NCT01154764
completedphase_3

Phase III Study of CG100649 in Osteoarthritis Patients

NCT01765296
completedphase_2

Study of CG100649 Versus Celecoxib in Osteoarthritis Patients

NCT01341405
completedphase_1

Phase I Study on Multiple Oral Dosing of CG100649

NCT01154790
unknownphase_2

Phase II Study of CG100649 for Primary Osteoarthritis in Male Subjects

NCT00530452

Clinical Trials (5)

Showing 5 of 5 trials
NCT01154764Phase 1

Trial for Studying Pharmacokinetic Effects of Ketoconazole on CG100649

Completed
NCT01765296Phase 3

Phase III Study of CG100649 in Osteoarthritis Patients

Completed
NCT01341405Phase 2

Study of CG100649 Versus Celecoxib in Osteoarthritis Patients

Completed
NCT01154790Phase 1

Phase I Study on Multiple Oral Dosing of CG100649

Completed
NCT00530452Phase 2

Phase II Study of CG100649 for Primary Osteoarthritis in Male Subjects

Unknown

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5